Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Clozapine for Treatment-Resistant Schizophrenia
View through CrossRef
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia. This clinical trial, conducted by Kane and colleagues, asks whether clozapine is an effective option in the care of patients with treatment-resistant schizophrenia who have not responded to past trials of first-generation antipsychotics. To answer this question, the chapter reviews the basics of the study, including funding sources, study location, inclusion and exclusion criteria, number of participants, research design, interventions, follow-up, endpoints, results, criticisms, and limitations. The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.
Title: Clozapine for Treatment-Resistant Schizophrenia
Description:
This chapter provides a summary of a landmark study on the pharmacologic management of treatment-resistant schizophrenia.
This clinical trial, conducted by Kane and colleagues, asks whether clozapine is an effective option in the care of patients with treatment-resistant schizophrenia who have not responded to past trials of first-generation antipsychotics.
To answer this question, the chapter reviews the basics of the study, including funding sources, study location, inclusion and exclusion criteria, number of participants, research design, interventions, follow-up, endpoints, results, criticisms, and limitations.
The chapter briefly reviews other relevant studies and information, discusses implications, and concludes with a relevant clinical case.
Related Results
Schizophrenia
Schizophrenia
Schizophrenia is one of the most misunderstood and stigmatized mental illnesses. Discover the truth about this condition, which affects roughly 25 million people worldwide.
...
Late-onset schizophrenia
Late-onset schizophrenia
Although schizophrenia with onset in middle or late-life is a relatively uncommon, a considerable proportion of patients do experience the first manifestations of the disease after...
Emil Kraepelin
Emil Kraepelin
Emil Kraepelin, professor of psychiatry first in Heidelberg then Munich, originated modern psychiatric diagnosis. So it was a fateful error when, in 1899, Kraepelin made catatonia ...
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
The ontology and epistemology of symptoms: The case of auditory verbal hallucinations in schizophrenia
We present a phenomenological account of auditory verbal hallucinations (AVH) in schizophrenia. We examine the mode of articulation of AVH, their spatial and temporal characteristi...
Life's rewards
Life's rewards
Life’s Rewards: Linking Dopamine, Incentive Learning, Schizophrenia, and the Mind explains how increased brain dopamine produces reward-related incentive learning, the acquisition ...
Interventions
Interventions
Despite the fact that suicide is one of the leading causes of death in the United States, there are currently no US Food and Drug Administration-approved treatments for suicidal be...
Eugen Bleuler
Eugen Bleuler
Eugen Bleuler, professor of psychiatry in Zurich, renamed Kraepelin’s dementia praecox as “schizophrenia” in 1908. He retained catatonia as a subtype. Bleuler’s dementia praecox wa...
Neurodevelopment and Schizophrenia
Neurodevelopment and Schizophrenia
This book was originally published in 2004 and concerns developmental neurobiology. In the decade preceding publication, developmental neurobiology made important strides towards e...